시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 조직학 및 세포학 시장 규모, 점유율 및 동향 분석 보고서 - 유형별, 제품별, 시험 유형별, 용도별, 최종 사용자별, 지역별 전망 및 예측(2024-2031년)
Global Histology and Cytology Market Size, Share & Trends Analysis Report By Type, By Product (Consumable & Reagents, and Instruments & Analysis Software System), By Test Type, By Application, By End User, By Regional Outlook and Forecast, 2024 - 2031
상품코드 : 1473057
리서치사 : KBV Research
발행일 : 2024년 04월
페이지 정보 : 영문 325 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,206,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,248,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,747,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

조직학 및 세포학 시장 규모는 예측 기간 동안 13.8%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 438억 달러에 달할 것으로 예상됩니다.

또한, 지구상의 모든 국가에서 노인 인구가 위험할 정도로 빠르게 증가하고 있습니다. 노인 인구는 2050년까지 약 15억 명에 달할 것으로 예측됩니다. 2050년까지 노인 인구는 전 세계 인구의 16.0%를 차지할 것으로 예상됩니다. 따라서 고령화 인구 증가는 노화 관련 질병의 확산을 촉진하고 조직학 및 세포학 검사에 대한 수요를 촉진할 것입니다.

코로나19 팬데믹은 조직학 및 세포학 분야에 큰 영향을 미쳤으며, 도전과 기회를 동시에 가져왔습니다. 전 세계 의료 시스템이 전례 없는 부담에 직면한 가운데, 코로나19 환자 관리에 자원을 우선적으로 투입하기 위해 정기적인 조직학 및 세포학 검사를 포함한 많은 비응급 의료 절차가 연기되거나 축소되었습니다. 이러한 혼란으로 인해 암 검진 및 진단이 지연되어 환자 결과에 영향을 미치고 사례가 쌓일 수 있습니다. 따라서 전염병은 전반적으로 시장에 긍정적인 영향을 미쳤습니다.

그러나 조직학 및 세포학 실험실에서는 표본 처리, 염색, 이미징 및 분석을 위한 특수 장비, 시약 및 소모품이 필요합니다. 장비 구입 및 유지 보수에 드는 초기 비용과 시약 조달 및 품질 관리와 관련된 지속적인 비용이 전체 테스트 비용에 영향을 미칩니다. 따라서 높은 비용으로 인해 시장 발전이 어느 정도 제한될 수 있습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 세계 시장 : 시험 유형별

제5장 세계 시장 : 제품별

제6장 세계 시장 : 시험 유형별

제7장 세계 시장 : 용도별

제8장 세계 시장 : 최종사용자별

제9장 세계 시장 : 지역별

제10장 기업 개요

제11장 조직학 및 세포학 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Histology and Cytology Market size is expected to reach $43.8 billion by 2031, rising at a market growth of 13.8% CAGR during the forecast period.

Histology and cytology services are in greater demand in the Asia-Pacific region because of the increasing incidence of cancer and the prevalence of chronic diseases. Thus, the Asia Pacific region acquired 25% revenue share in 2023. The Asia Pacific region represents a dynamic and rapidly growing market in histology and cytology, driven by increasing healthcare spending, rising prevalence of chronic diseases, and expanding access to diagnostic services.

Personalized medicine entails customizing medical interventions to accommodate the unique attributes of individual patients, including, but not limited to, their lifestyle, environment, and genetic composition. Thus, as personalized medicine continues, the demand for advanced histology and cytology tests that can provide detailed molecular information is expected to grow.

Additionally, the elderly population is increasing dangerously quickly in every nation on Earth. Its population is projected to reach approximately 1.5 billion people by 2050. Seniors are expected to make up 16.0% of the world's population by 2050.Therefore, the increasing aging population drives the demand for histological and cytological testing by fueling the prevalence of age-related diseases.

The COVID-19 pandemic profoundly impacted the field of histology and cytology, introducing both challenges and opportunities. With healthcare systems worldwide facing unprecedented strain, many non-urgent medical procedures, including routine histological and cytological examinations, were postponed or scaled back to prioritize resources for managing COVID-19 patients. This disruption led to delays in cancer screenings and diagnoses, potentially affecting patient outcomes and contributing to a backlog of cases. Thus, the pandemic had an overall positive impact on the market.

However, Histology and cytology laboratories require specialized equipment, reagents, and consumables for specimen processing, staining, imaging, and analysis. The upfront costs of purchasing and maintaining equipment and the ongoing expenses associated with reagent procurement and quality control contribute to the overall cost of testing. Hence, the high cost may limit the development of the market to some extent.

By Type of Examination Analysis

By type of examination, the market is bifurcated into cytology and histology. The cytology segment procured the maximum, 78.4% revenue share in the market in 2023. The segment is growing owing to the rising need for cytology services. As the population ages and grows, the incidence of cancer is also expected to increase, leading to a higher demand for cytology services.

By Product Analysis

Based on product, the market is characterized by instruments & analysis software system and consumable & reagents. The instruments & analysis software system segment garnered a significant 39.4% revenue share in the market in 2023. Instruments and analysis software systems are essential to the market, facilitating tissue and cellular specimens' processing, examination, and interpretation.

By Test Type Analysis

On the basis of test type, the market is classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment acquired 54.3% revenue share in the market in 2023. Advancements in imaging technology, automation, and software integration offer enhanced histological and cytological analysis capabilities.

By Application Analysis

On the basis of application, the market is characterized by drug discovery & designing, clinical diagnostics, and academic research. The clinical diagnostics segment recorded a remarkable 38% revenue share in the market in 2023. Clinical diagnostics are pivotal in boosting the market by providing essential tools and techniques for disease diagnosis, patient management, and treatment optimization.

By End User Analysis

By end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. The pharma & biotech companies segment procured 39.1% revenue share in the market in 2023. Pharmaceutical and biotechnology companies significantly boost the market by contributing to drug discovery, development, and personalized medicine initiatives.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 40% revenue share in market in 2023. With a robust network of diagnostic laboratories, academic institutions, and healthcare facilities, North America leads in adopting innovative technologies and practices within the field.

List of Key Companies Profiled

Global Histology and Cytology Market Report Segmentation

By Type of Examination

By Product

By Test Type

By Application

By End User

By Geography

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Global Histology and Cytology Market by Type of Examination

Chapter 5.Global Histology and Cytology Market by Product

Chapter 6.Global Histology and Cytology Market by Test Type

Chapter 7.Global Histology and Cytology Market by Application

Chapter 8.Global Histology and Cytology Market by End User

Chapter 9.Global Histology and Cytology Market by Region

Chapter 10.Company Profiles

Chapter 11.Winning imperatives of Histology and Cytology Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기